Authors: Bear, HD Roberts, J Cornell, D Tombes, MB Kyle, B

Citation: Hd. Bear et al., Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial, CANCER IMMU, 50(5), 2001, pp. 269-274

Authors: Kyle, B

Citation: B. Kyle, USE helps connect the enterprise, CONTROL ENG, 48(1), 2001, pp. 10-10

Authors: Roberts, JD Shibata, S Spicer, DV McLeod, HL Tombes, MB Kyle, B Carroll, M Sheedy, B Collier, MA Pithavala, YK Paradiso, LJ Clendeninn, NJ

Citation: Jd. Roberts et al., Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks, CANC CHEMOT, 45(5), 2000, pp. 423-427

Authors: Roberts, JD Poplin, EA Tombes, MB Kyle, B Spicer, DV Grant, S Synold, T Moran, R

Citation: Jd. Roberts et al., Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation, CANC CHEMOT, 45(2), 2000, pp. 103-110

Authors: Freeman, DA Cymbaluk, NF Schott, HC Hinchcliff, K McDonnell, SM Kyle, B

Citation: Da. Freeman et al., Clinical, biochemical, and hygiene assessment of stabled horses provided continuous or intermittent access to drinking water, AM J VET RE, 60(11), 1999, pp. 1445-1450

Authors: McDonnell, SM Freeman, DA Cymbaluk, NF Schott, HC Hinchcliff, K Kyle, B

Citation: Sm. Mcdonnell et al., Behavior of stabled horses provided continuous or intermittent access to drinking water, AM J VET RE, 60(11), 1999, pp. 1451-1456